Boston Scientific Corporation P/E Ratio 2007–2025
Boston Scientific Corporation reported 49.15 of price-to-earnings ratio for fiscal 2025. That was 31.2% lower than fiscal 2024. Compared with fiscal 2019, the change was +261.9%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 49.15 | -31.2% |
| FY 2024 | 71.46 | +32.3% |
| FY 2023 | 54.03 | -47.5% |
| FY 2022 | 102.82 | +67.0% |
| FY 2021 | 61.57 | — |
| FY 2020 | — | — |
| FY 2019 | 13.58 | -54.3% |
| FY 2018 | 29.70 | -90.4% |
| FY 2017 | 309.88 | +258.2% |
| FY 2016 | 86.52 | — |
| FY 2015 | — | — |
| FY 2014 | — | — |
| FY 2013 | — | — |
| FY 2012 | — | — |
| FY 2011 | 18.41 | — |
| FY 2010 | — | — |
| FY 2009 | — | — |
| FY 2008 | — | — |
| FY 2007 | — | — |
Source: Boston Scientific Corporation SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open BSX 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Boston Scientific Corporation reported 49.15 of price-to-earnings ratio for fiscal 2025. That was 31.2% lower than fiscal 2024. Compared with fiscal 2019, the change was +261.9%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Boston Scientific Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeBoston Scientific Corporation — frequently asked questions
What is Boston Scientific Corporation's price-to-earnings ratio?
Boston Scientific Corporation (BSX) reported price-to-earnings ratio of 49.15 for fiscal year 2025, per its SEC filings.
How has Boston Scientific Corporation's price-to-earnings ratio changed over time?
Between fiscal 2007 and 2025, BSX's price-to-earnings ratio grew at roughly 5.6% per year (compound annual rate), from 18.41 to 49.15.
Where does this data come from?
Figures are computed from Boston Scientific Corporation's official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More BSX financial history
Full BSX fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →